Skip to content
MedsAcross

Brand family

Fetzima

Levomilnacipran · Allergan
United States
Presentations
5
Markets
1

Fetzima is a brand of Levomilnacipran marketed by Allergan, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Levomilnacipran
Brand owner
Allergan
Registered in
United States
Strengths and forms
120 mg extended-release capsule, 20 mg extended-release capsule, 40 mg extended-release capsule, 80 mg extended-release capsule, kit

All presentations

MedicineManufacturerRegisterAvailability
Fetzima 120 mg extended-release capsuleOralAllerganUS FDAAvailable on request
Fetzima 20 mg extended-release capsuleOralAllerganUS FDAAvailable on request
Fetzima 40 mg extended-release capsuleOralAllerganUS FDAAvailable on request
Fetzima 80 mg extended-release capsuleOralAllerganUS FDAAvailable on request
Fetzima kitOralAllerganUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Fetzima

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.